Tonix Pharmaceuticals to Present at Two Investor Conferences in March 2016
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Tonix Pharmaceuticals (TNXP) Misses Q4 EPS by 5c
March 4, 2016 7:01 AM ESTTonix Pharmaceuticals (NASDAQ: TNXP) reported Q4 EPS of ($0.71), $0.05 worse than the analyst estimate of ($0.66).
For earnings history and earnings-related data on Tonix Pharmaceuticals (TNXP) click here.
... More